OGLUO Solution for injection Ref.[50398] Active ingredients: Glucagon

Source: European Medicines Agency (EU)  Revision Year: 2022  Publisher: Tetris Pharma B.V, Bargelaan 200, Element Offices, 2333 CW Leiden, Netherlands

Product name and form

Ogluo 0.5 mg solution for injection in pre-filled pen.

Ogluo 1 mg solution for injection in pre-filled pen.

Ogluo 0.5 mg solution for injection in pre-filled syringe.

Ogluo 1 mg solution for injection in pre-filled syringe.

Pharmaceutical Form

Solution for injection (injection).

A clear, colourless to pale yellow solution.

Qualitative and quantitative composition

Ogluo 0.5 mg solution for injection in pre-filled pen: Each pre-filled pen contains 0.5 mg glucagon in 0.1 mL.

Ogluo 1 mg solution for injection in pre-filled pen: Each pre-filled pen contains 1 mg glucagon in 0.2 mL.

Ogluo 0.5 mg solution for injection in pre-filled syringe: Each pre-filled syringe contains 0.5 mg glucagon in 0.1 mL.

Ogluo 1 mg solution for injection in pre-filled syringe: Each pre-filled syringe contains 1 mg glucagon in 0.2 mL.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Glucagon

Glucagon is a hyperglycaemic agent that mobilises hepatic glycogen, which is released into the blood as glucose. Glucagon inhibits the tone and motility of the smooth muscle in the gastrointestinal tract.

List of Excipients

Trehalose dihydrate
Dimethyl sulfoxide (DMSO)
Sulfuric acid
Water for injections

Pack sizes and marketing

Ogluo 0.5 mg solution for injection in pre-filled pen:

A pre-filled, single-dose pen containing a 1 mL cyclic olefin polymer syringe with ETFE coated chlorobutyl rubber piston, 27-gauge staked stainless steel needle,bromo butyl rubber flexible needle shield, and a red cap.

Each pre-filled pen contain 0.1 mL of solution for injection and is individually packaged in a predominantly red-coloured foil pouch, in a red on white carton displaying a pre-filled pen image.

Pack sizes of one and two single-dose pre-filled pens.

Ogluo 1 mg solution for injection in pre-filled pen:

A pre-filled, single-dose pen containing a 1 mL cyclic olefin polymer syringe with ETFE coated chlorobutyl rubber piston, 27-gauge staked stainless steel needle,bromo butyl rubber flexible needle shield, and a red cap.

Each pre-filled pen contains 0.2 mL of solution for injection and is individually packaged in a predominantly blue-coloured foil pouch, in a blue on white carton displaying a pre-filled pen image.

Pack sizes of one and two single-dose pre-filled pens.

Ogluo 0.5 mg solution for injection in pre-filled syringe:

A pre-filled 1 mL cyclic olefin polymer syringe with ETFE coated chlorobutyl rubber piston, 27-gauge staked stainless steel needle, and bromo butyl rubber rigid needle shield. Each syringe contains 0.1 mL of solution for injection and is individually packaged in a predominantly red-coloured foil pouch, in a red on white carton displaying a pre-filled syringe image.

Pack sizes of one and two single-dose pre-filled syringes.

Ogluo 1 mg solution for injection in pre-filled syringe:

A pre-filled 1 mL cyclic olefin polymer syringe with ETFE coated chlorobutyl rubber piston, 27-gauge staked stainless steel needle, and bromo butyl rubber rigid needle shield. Each syringe contains 0.2 mL of solution for injection and is individually packaged in a predominantly blue-coloured foil pouch, in a blue on white carton displaying a pre-filled syringe image.

Pack sizes of one and two single-dose pre-filled syringes.

Not all pack sizes may be marketed.

Marketing authorization holder

Tetris Pharma B.V, Bargelaan 200, Element Offices, 2333 CW Leiden, Netherlands

Marketing authorization dates and numbers

EU/1/20/1523/001
EU/1/20/1523/002
EU/1/20/1523/003
EU/1/20/1523/004
EU/1/20/1523/005
EU/1/20/1523/006
EU/1/20/1523/007
EU/1/20/1523/008

Date of first authorisation: 11 February 2021

Drugs

Drug Countries
OGLUO Estonia, Ireland, Lithuania, Poland

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.